rmf.hapres.com Review Clinical Perspectives on 3D Bioprinting Paradigms for Regenerative Medicine Sadi Loai 1,2,†, Benjamin R. Kingston 1,†, Zongjie Wang 1,3,†, David N. Philpott 3,†, Mingyang Tao 1, Hai-Ling Margaret Cheng 1,2,3,* 1 Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto M5S 3G9, Canada 2 Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Toronto M5G 1M1, Canada 3 The Edwards S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto M5S 3G4, Canada † These authors contributed equally to this work. * Correspondence: Hai-Ling Margaret Cheng, Email:
[email protected]; Tel.: +1-416-978-4095. ABSTRACT Three-dimensional (3D) bioprinting is an emerging manufacturing technology that layers living cells and biocompatible natural or synthetic materials to build complex, functional living tissue with the requisite 3D geometries. This technology holds tremendous promise across a plethora of applications as diverse as regenerative medicine, pathophysiological studies, and drug testing. Despite some success demonstrated in early attempts to recreate complex tissue structures, however, the field of bioprinting is very much in its infancy. There are a variety of challenges to building viable, functional, and lasting 3D structures, not the least of which is translation from a research to a clinical setting. In this review, the current translational status of 3D bioprinting is assessed for several major tissue types in the body (skin, bone/cartilage, cardiovascular, central/peripheral nervous systems, skeletal muscle, kidney, and liver), recent breakthroughs and current challenges are highlighted, and future prospects for this exciting research field are discussed.